OUR MISSION

To build and revolutionise the European cannabis space while fervently committing to creating high quality CBD products for the modern consumer.

Production

100% Swiss Made

Holyworld SA is a leading producer of cannabis-derived CBD products in Switzerland and Europe. We are actively involved in helping modernise the cannabis industry at global scale.

Founded in January 2018 by a group of dynamic entrepreneurs, Holyworld SA is now a subsidiary of one of the world’s biggest cannabis conglomerates: MPXI Corporation. In search of excellence and constant innovation, opportunities are made possible by an emerging global industry where consumer experience is at heart of what we do, ensuring our brands reflect the tastes, preferences and values of current and future customers.

Our crops are certified organic, grown along the shores of Lake Geneva near facilities located between the lake the Alps, and our products are Swiss-made, and tobacco and additive free.

Production

BIO Organic Certified

For more than 3 years, our BIO organic certification guaranties that our cultivation, harvesting, drying, manicuring and curing processes respect intrinsic qualities of the plant and abide to sustainable practices, making our the superior quality products unanimously recognized on the market.

All our Swiss-made and premium quality CBD products are grown, manufactured, and designed for the modern consumer and serve as the forerunners of the industry.

Real time MPXI stock ticker

Award winning

HolyWorld SA is an international subsidiary of the award-winning cannabis pioneer MPXI. Since 2015, MPX Bioceutical has been developing innovative cannabis operations and award-winning products across both consumer and medical industries in North America. The managers of MPX Bioceutical scaled it from a single Licensed Producer into one of the largest vertically-integrated, multi-state operators in the USA.

MPX Bioceutical was acquired in 2019 for $835 million CAD. The sale and subsequent spin-off of MPX International Corporation (MPXI) created the opportunity to replicate the success experienced in North America on a global scale.

It is in our DNA to value sustainability, innovation and quality, and MPXI believes that developing a long-term, international footprint, encompassing all levels of the value chain is key.

Founded MPX Bioceutical in

2015

Retail locations opened

12

Scaled our annual production to

8850kg

Revenue Run-Rate

$100milion+

Debt and Equity Financing

$105million+

Sold in 2018 for

$835million

Founded MPX Bioceutical in

2015

States expanded into

5

Retail locations opened

12

Premium SKUs

145+

Scaled our annual production to

8850kg

Debt and Equity Financing

$105million+

Melting Point Extracts (MPX) is our award-winning cannabis brand, devoted to providing the cleanest and most effective products possible. MPX specializes in Hydrocarbon, CO2, and solvent-free extractions to provide a diverse line of high-quality products including live resin concentrates, wax, sauce, and diamonds.

Meet

OUR TEAM

Management

Alastair Crawford

CEO

Harnoor Grewall

Strategy & Corporate Development

Louis-Philippe Escudié

Business Development

Andrea Bambi

eCommerce

Gail Ford Hills

Retail

Imre Orban

Finance

Directors of Board

Scott Boyes

President

Jeremy Budd

Secretary

Alastair Crawford

Director

Harnoor Grewall

Director

Louis-Philippe Escudié

Director

Strategic Advisors

Harper Dennis Hobbs

Retail

Jean-Marc Levy

Product & Marketing

Rachel Day

Branding & Marketing

Management MPXI

Scott Boyes

CEO and Chairman

Jeremy Budd

Executive Vice President and General Counsel

Jeremy Blumer

CFO

Alastair Crawford

CEO, Europe

Discover

OUR ACTIVITIES

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.